|
70
|
240
|
5l5zC |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
69
|
243
|
5l5uF |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
68
|
213
|
5lf1L |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
69
|
242
|
5l5rD |
Yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) |
|
66
|
231
|
5l5rE |
Yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) |
|
63
|
241
|
5l6cG |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
56
|
202
|
5lezN |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
|
69
|
243
|
5l66F |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
|
67
|
242
|
5m2bD |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19 |
|
58
|
204
|
5l61I |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (99-132) in complex with epoxyketone inhibitor 14 |
|
66
|
230
|
5lezA |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
|
59
|
196
|
5l5iN |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 9 |
|
58
|
204
|
5l69I |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
63
|
222
|
5l6aL |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
58
|
226
|
5l5pH |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
68
|
242
|
5l5wD |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) |
|
61
|
231
|
5l63E |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
66
|
240
|
5l5oC |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
60
|
195
|
5lttJ |
Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924 |
|
63
|
241
|
5l6bG |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with onx 0914 |
|
59
|
196
|
5l5uN |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
58
|
222
|
5l65L |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
65
|
250
|
5l60A |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
68
|
233
|
5l62M |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
62
|
231
|
5l54E |
Yeast 20s proteasome in complex with epoxyketone inhibitor 16 |
|
58
|
226
|
5l5iH |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 9 |
|
65
|
211
|
5l5sK |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
71
|
244
|
5l5pB |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
72
|
212
|
5l52K |
Yeast 20s proteasome in complex with epoxyketone inhibitor 14 |
|
60
|
226
|
5l5xH |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
|
67
|
250
|
5l5bA |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) |
|
67
|
233
|
5l5hM |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
61
|
222
|
5l5jL |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
|
58
|
204
|
5l5bI |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) |
|
69
|
240
|
5l5jC |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
|
56
|
222
|
5l55H |
Yeast 20s proteasome in complex with epoxyketone inhibitor 18 |
|
59
|
226
|
5l5sH |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
59
|
196
|
5l55N |
Yeast 20s proteasome in complex with epoxyketone inhibitor 18 |
|
65
|
233
|
5l5iM |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 9 |
|
60
|
222
|
5l5oL |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
64
|
211
|
5l5rK |
Yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) |
|
68
|
242
|
5l5qD |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone 18 |
|
60
|
196
|
5l5bN |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) |
|
59
|
226
|
5l5fH |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
59
|
195
|
5l5pJ |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
71
|
243
|
5l52F |
Yeast 20s proteasome in complex with epoxyketone inhibitor 14 |
|
62
|
211
|
5l5fK |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
58
|
196
|
5l5xN |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
|
62
|
211
|
5l5aK |
Yeast 20s proteasome with human beta5i (1-138; r57t) |
|
60
|
196
|
5l5fN |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
